What indicators would you like to setup a trade for?

Candlestick Daily volume index Bar reversal Edit

Trade setup

Position Order Entry Exit Stop Loss Risk Return Expectancy
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

Company

Indicator

Code Company Date Close Change Indicator Value Signal

Trading Performance

Range Change

Score

0.65

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 82 5.0 0.54% 0.85% 9.2% -2.5% 276.3%
SHORT 82 5.9 0.52% 0.88% 3.2% -2.7% 7.9%

Summary

Technical Analysis


The range of the bar gives important information about the strength of weakness of a trend. If buyers are very committed they will be keen to buy and will tend to bid the price up even in the face of some selling pressure. Price will quickly & easily move upward and the move will tend to be significant. As such expanding ranges indicate the either buyers or sellers becoming more committed. Alternatively once the range begins to contract the side in control are losing commitment.

Calculation: Range Today Versus Range Yesterday (RTRY):
1) Expanding ranges on the upside indicates that buyers are increasingly eager;
2) Expanding ranges on the downside indicates that sellers are increasingly eager;
3) Contracting ranges on the upside indicates that buyers are becoming less eager;
4) Contracting ranges on the downside indicates that sellers are becoming less eager;


PROFILE: Opthea (OPT.AX)


Stock Exchange: ASX
Company: Opthea
Ticker Codes: | OPT.AX | ASX:OPT |

About Opthea (ASX:OPT):

Opthea Limited develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) C and D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3, which is in Phase 1/2A clinical trial for the treatment of back of the eye diseases, such as wet age-related macular degeneration that is the cause of blindness in elderly and diabetic populations. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited is based in South Yarra, Australia.

Top 10:

Range Change

Download
Company Close Change(%) Volume Value Signal
MLX Metals X 0.11 8.2 3,754,499 0 BEARISH
MGX Mount Gibson Iron 0.91 7.1 3,615,391 -1 BEARISH
OZL Oz Minerals 11.2 4.9 5,194,266 0 BEARISH
AMP AMP 1.95 4.3 12,225,446 0 BEARISH
MFG Magellan Financial 55.88 3.7 467,863 -1 BEARISH
MYX Myx 0.45 3.5 3,638,020 0 BEARISH
MCP Mcphersons 2.4 3.4 693,722 -1 BEARISH
PGC Paragon Care 0.45 3.4 104,267 -1 BEARISH
KAR Karoon Gas Australia 1.09 3.3 934,163 -1 BEARISH
AVJ Av Jennings Homes 0.63 3.3 290,633 -1 BEARISH